Dr Reddy's Launches First Generic Bosulif in US, Secures 180-Day Exclusivity for Bosutinib 400mg sheeba farhat13 Jun 2026 11:30 AM ISTHyderabad: Dr. Reddy's Laboratories Ltd. has announced the first-to-market launch of Bosutinib Tablets 400mg, a generic equivalent of Bosulif, in the...
Naprod Seeks Higher NPPA Ceiling Prices for Cisplatin, Carboplatin Amid Cancer Drug Supply Crunch Susmita Roy8 Jun 2026 11:00 PM ISTNew Delhi: Oncology drug manufacturer Naprod Life Sciences has approached the National Pharmaceutical Pricing Authority (NPPA) seeking an upward...
Pfizer Signs USD 10.5 Billion Cancer Drug Deal with China's Innovent Biologics sheeba farhat29 May 2026 10:00 AM ISTBengaluru: China's Innovent Biologics and U.S. pharma giant Pfizer have agreed to a global licensing and collaboration deal worth up to USD 10.5...
Fake Cancer, BP Drugs Sold via Facebook at 50% Discount, STF Busts Illegal Pharma Unit in Roorkee Parthika Patel27 May 2026 10:05 PM ISTNew Delhi: A major fake medicine racket linked to an illegal pharmaceutical manufacturing unit in Uttarakhand's Roorkee has come under investigation...
Sakar Healthcare Signs Oncology Supply Pact with Zydus for GCC, Emerging Markets sheeba farhat25 May 2026 12:30 PM ISTNew Delhi: Drug firm Sakar Healthcare on Thursday said it has signed an agreement with Zydus Lifesciences for the supply of oncology products across...
Delhi Police Busts Rs 10 Crore Syndicate Supplying Fake Cancer, Liver Disease Drugs, 4 Held Parthika Patel8 May 2026 5:17 PM ISTNew Delhi: Delhi Police has busted a counterfeit medicine racket worth nearly Rs 10 crore and arrested four persons allegedly involved in...
Gilead to Acquire Tubulis for USD 5 Billion to Strengthen Cancer Pipeline sheeba farhat9 April 2026 4:43 PM ISTBengaluru: Gilead said on Tuesday it would acquire Germany-based Tubulis GmbH for up to USD 5 billion, as it looks to strengthen its cancer drugs...
Pharma Firms Seek 50% Price Hike in Key Cancer Drugs Including Carboplatin, Cisplatin, Approach NPPA: Report Parthika Patel6 April 2026 9:20 PM ISTNew Delhi: Domestic drug manufacturers have sought a 50% increase in prices of key cancer medicines such as carboplatin, cisplatin and oxaliplatin,...
Intas Pharma Barred from Using Cancer Drug Brand BEVATAS Similar to Sun Pharma's BEVETEX Susmita Roy3 April 2026 3:23 PM ISTNew Delhi: In a significant ruling on pharmaceutical trademark infringement, the Delhi High Court in the case of Sun Pharma Laboratories Limited vs...
Setback to Sun Pharma as Fibromun, Nidlegy Trials Miss Key Endpoints in Cancer Studies Parthika Patel28 March 2026 8:37 PM ISTNew Delhi: Sun Pharmaceutical Industries Limited has shared clinical updates on Fibromun and Nidlegy, with key studies failing to meet primary...
Bristol Myers Squibb Wins USFDA Approval for Opdivo Combo in Hodgkin Lymphoma sheeba farhat23 March 2026 11:15 AM ISTBengaluru: The U.S. Food and Drug Administration said on Friday it approved Bristol Myers Squibb's combination treatment for adults and adolescents...
Pharma Companies Told to Cut Prices of 17 Duty Exempt Cancer Drugs Susmita Roy13 Feb 2026 8:41 PM ISTNew Delhi: In a follow-up to the customs duty relief on essential medicines, the National Pharmaceutical Pricing Authority (NPPA) has directed...
